Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Clinical trial NCT01079780 · COMPLETED
Trial details
- NCT number
- NCT01079780
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-18
- Primary completion
- 2021-02-22
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.